The health care burden and societal impact of acute otitis media in seven European countries: Results of an Internet survey

Vaccine

Volumn 28, Issue SUPPL. 6, 2010, Pages

  Wolleswinkel van den Bosch, Judith H ^a   Stolk, Elly A ^b   Francois, Martine ^c   Gasparini, Roberto ^d   Brosa, Max ^e  

^a Pallas Health Research and Consultancy   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c HÔPITAL ROBERT DEBRÉ   (France)

^d UNIVERSITY OF GENOA   (Italy)

^e Oblikue Consulting   (Spain)

Author keywords

Acute otitis media; Direct costs; Indirect costs

Indexed keywords

ACUTE OTITIS MEDIA; ANTIBIOTIC THERAPY; ARTICLE; BELGIUM; COST OF ILLNESS; FRANCE; GERMANY; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEALTH SURVEY; HUMAN; INTERNET; ITALY; MEDICAL CARE; NETHERLANDS; PRIORITY JOURNAL; QUESTIONNAIRE; SPAIN; UNITED KINGDOM;

CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; EFFICIENCY; EUROPE; HEALTH CARE COSTS; HEALTH FACILITIES; HUMANS; INFANT; INFANT, NEWBORN; INTERNET; OTITIS MEDIA; QUESTIONNAIRES;

EID: 78249266595     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.06.014     Document Type: Article

References (36)

1. Neff M.J. AAP, AAFP release guideline on diagnosis and management of acute otitis media. Am Fam Physician 2004, 69(11):2713-2715.
2. Rovers M.M., Schilder A.G., Zielhuis G.A., Rosenfeld R.M. Otitis media. Lancet 2004, 363(9407):465-473.
3. O'Neill P. Acute otitis media. BMJ 1999, 319(7213):833-835.
4. Rosenfeld R.M., Kay D. Natural history of untreated otitis media. Laryngoscope 2003, 113(10):1645-1657.
5. Rovers M.M., Glasziou P., Appelman C.L., Burke P., McCormick D.P., Damoiseaux R.A., et al. Predictors of pain and/or fever at 3 to 7 days for children with acute otitis media not treated initially with antibiotics: a meta-analysis of individual patient data. Pediatrics 2007, 119(3):579-585.
6. Roberts J.E., Rosenfeld R.M., Zeisel S.A. Otitis media and speech and language: a meta-analysis of prospective studies. Pediatrics 2004, 113(3 Pt 1):e238-e248.
7. Brauer M., Gehring U., Brunekreef B., de Jongste J., Gerritsen J., Rovers M., et al. Traffic-related air pollution and otitis media. Environ Health Perspect 2006, 114(9):1414-1418.
8. Garcés-Sánchez M., Díez-Domingo J., Alvarez de Labiada T., Planelles V., Graullera M., Baldo J.M., et al. Epidemiology and burden of acute otitis media in Valencia (Spain). Ann Pediatr (Barc) 2004, 60(2):125-132.
9. Rovers M.M., Glasziou P., Appelman C.L., Burke P., McCormick D.P., Damoiseaux R.A., et al. Antibiotics for acute otitis media: a meta-analysis with individual patient data. Lancet 2006, 368(9545):1429-1435.
10. Schilder A.G., Lok W., Rovers M.M. International perspectives on management of acute otitis media: a qualitative review. Int J Pediatr Otorhinolaryngol 2004, 68(1):29-36.
11. Agence Française de Sécurité Sanitaire des Produits de Santé (AFSSPS). Systemic antibiotic treatment in upper and lower respiratory tract infections: official French guidelines. Clin Microbiol Infect 2003;9(12):1162-78.
12. Regione Emilia-Romagna. Otite media acuta in età pediatrica. Linea guida regionale. Dossier No. 154; 2007.
13. Marchetti F., Ronfani L., Nibali S.C., Tamburlini G. Delayed prescription may reduce the use of antibiotics for acute otitis media: a prospective observational study in primary care. Arch Pediatr Adolesc Med 2005, 159(7):679-684. Italian Study Group on Acute Otitis Media.
14. Bos J.M., Rümke H., Welte R., Postma M.J. Epidemiologic impact and cost-effectiveness of universal infant vaccination with a 7-valent conjugated pneumococcal vaccine in the Netherlands. Clin Ther 2003, 25(10):2614-2630.
15. Niemela M., Uhari M., Mottonen M., Pokka T. Cost arising from otitis media. Acta Pediatr 1999, 88:553-556.
16. Capra A.M., Lieu T.A., Black S.B., Shinefield H.R., Martin K.E., Klein J.O. Costs of otitis media in a managed care population. Pediatric Infect Dis J 2000, 19(4):354-355.
17. European Foundation for the improvement of living and working conditions; 2007.
18. Oostenbrink J.B., Bouwmans C.A.M., Koopmanschap M.A., Rutten F.F.H. Manual for costing: methods and standard costs for economic evaluations in health care 2004, Health Insurance Board, Diemen, The Netherlands.
19. Brouwer W.B.F., Koopmanschap M.A., Rutten F.F.H. Productivity losses without absence: measurement validation and empirical evidence. Health Policy 1999, 48:13-27.
20. Koopmanschap M.A. PRODISQ: a modular questionnaire on productivity and disease for economic evaluation studies. Expert Rev Pharmacoeconomics Outcomes Res 2005, 5(1):23-28.
21. Van Roijen L., Essink-Bot M.L., Koopmanschap M.A., Bonsel G., Rutten F.F.H. Labour and health status in economic evaluation of health care: the Health and Labour Questionnaire. Int J Technol Assess Health Care 1996, 12:405-415.
22. CVZ (Health Care Insurance Board). Guidelines for pharmacoeconomic research, updated version. Diemen, The Netherlands; March 2006.
23. Durán A., Lara J.L., van Waveren M. Spain: health system review. Health Syst Transit 2006, 8(4):1-208.
24. Plasschaert A.I., Rovers M.M., Schilder A.G., Verheij T.J., Hak E. Trends in doctor consultations, antibiotic prescription, and specialist referrals for otitis media in children: 1995-2003. Pediatrics 2006, 117(6):1879-1886.
25. Froom J., Culpepper L., Grob P., Bartelds A., Bowers P., Bridges-Webb C., et al. Diagnosis and antibiotic treatment of acute otitis media: report from International Primary Care Network. BMJ 1990, 300(6724):582-586.
26. Goossens H., Coenen S., Costers M., De Corte S., De Sutter A., Gordts B., et al. Achievements of the Belgian antibiotic policy coordination committee (BAPCOC). Eurosurveillance 2008, 13(46):1-4.
27. Petrou S., Murray L., Cooper P., Davidson L.L. The accuracy of self-reported healthcare resource utilization in health economic studies. Int J Technol Assess Health Care 2002, 18(3):705-710.
28. Bellón J.A., Lardelli P., Luna J.D., Delgado A. Validity of self reported utilisation of primary health care services in an urban population in Spain. J Epidemiol Community Health 2000, 54(7):544-551.
29. Ritter P.L., Stewart A.L., Kaymaz H., Sobel D.S., Block D.A., Lorig K.R. Self-reports of health care utilization compared to provider records. J Clin Epidemiol 2001, 54(2):136-141.
30. Vernacchio L., Vezina R.M., Ozonoff A., Mitchell A.A. Validity of parental reporting of recent episodes of acute otitis media: a Slone Center Office-Based Research (SCOR) Network study. J Am Board Fam Med 2007, 20(2):160-163.
31. Severens J.L., Mulder J., Laheij R.J.F., Verbeek A.L.M. Precision and accuracy in measuring absence from work as a basis for calculating productivity costs in The Netherlands. Social Sci Med 2000, 51:243-249.
32. Palmu A.A., Verho J., Jokinen J., Karma P., Kilpi T.M. The seven-valent pneumococcal conjugate vaccine reduces tympanostomy tube placement in children. Pediatr Infect Dis J 2004, 23(8):732-738.
33. Yawn B.P., Yawn R.A., Lydick E. The relative community burden of otitis media and varicella. Clin Ther 1996, 18(5):877-886.
34. Riquelme Pérez M., Rincón Víctor P., García Ruiz L., Tusset Castellano J., Bravo Tabares R., Fernández Pérez C. Acute otitis media in a pediatric primary care unit. Ann Pediatr (Barc) 2004, 61(5):408-412.
35. Williamson I., Benge S., Mullee M., Little P. Consultations for middle ear disease, antibiotic prescribing and risk factors for reattendance: a case-linked cohort study. Br J Gen Pract 2006, 56(524):170-175.
36. Angeloni S. Survey perspective on the epidemiology of otitis media and carriage of S. pneumoniae in children: an Italian experience. Proceedings of the 20th national congress on antibiotic therapy in paediatrics. Milan, Italy, November 22-23; 2001.